In another blow to Israeli shares, the Harvard Management Company notified the US Securities and Exchange Commission (SEC) on Friday that it had sold all its holdings in Israeli companies during the second quarter of 2010. No reason for the sale was mentioned. The Harvard Management Company manages Harvard University's endowment.
Harvard Management Company stated in its 13-F Form that it sold 483,590 shares in Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) for $30.5 million; 52,360 shares in NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE) for $1.67 million; 102,940 shares in Check Point Software Technologies Ltd. (Nasdaq: CHKP) for $3.6 million; 32,400 shares in Cellcom Israel Ltd. (NYSE:CEL; TASE:CEL) for $1.1 million, and 80,000 Partner Communications Ltd. (Nasdaq: PTNR; TASE: PTNR) shares for $1.8 million.
Harvard Management Company's 13-F Form shows some interesting investments. Its two largest holdings, each worth $295 million, are in... Chinese equities, and the other on emerging markets...
Makes perfect sense, doesn't it? Harvard has massive investments in China, the world's home of child slave labor as described over and over and over again by human rights activists.
Q: How many days a week do you work
A: Seven days. We start half past six in the morning and work 'til midnight.
Q: What toys are produced at the factory?
A: Dolls and dogs for Disney.
Just so I understand, Mr. and Mrs. Harvard University alumni, China's rampant use of slave labor and unbelievably nefarious pollution of the planet are swell.
But Israel's efforts to defend its tiny strip of land from swarms of intolerant extremists is somehow wrong.
I guess you have to possess a different sort of mindset to understand the reasoning.
Perhaps some Harvard alumni who might be concerned with this logic could pursue an inquiry into the rationale behind this divestiture.
Linked by: Michelle Malkin. Thanks!